160 related articles for article (PubMed ID: 25365107)
1. ESPOIR and the French database management: what have we learned from the first years of follow-up?
Combe B
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-153-7. PubMed ID: 25365107
[TBL] [Abstract][Full Text] [Related]
2. Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR.
Combe B; Rincheval N
Joint Bone Spine; 2015 Jan; 82(1):13-7. PubMed ID: 25238951
[TBL] [Abstract][Full Text] [Related]
3. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis).
Lukas C; Combe B; Ravaud P; Sibilia J; Landew R; van der Heijde D
Arthritis Rheum; 2011 Jul; 63(7):1804-11. PubMed ID: 21452295
[TBL] [Abstract][Full Text] [Related]
4. Databases of patients with early rheumatoid arthritis in the USA.
Sokka T; Willoughby J; Yazici Y; Pincus T
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S146-53. PubMed ID: 14969067
[TBL] [Abstract][Full Text] [Related]
5. Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort.
Bacconnier L; Rincheval N; Flipo RM; Goupille P; Daures JP; Boulenger JP; Combe B
Rheumatology (Oxford); 2015 Mar; 54(3):520-7. PubMed ID: 25224416
[TBL] [Abstract][Full Text] [Related]
6. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts.
van Nies JA; Tsonaka R; Gaujoux-Viala C; Fautrel B; van der Helm-van Mil AH
Ann Rheum Dis; 2015 May; 74(5):806-12. PubMed ID: 25561360
[TBL] [Abstract][Full Text] [Related]
7. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
Benhamou M; Rincheval N; Roy C; Foltz V; Rozenberg S; Sibilia J; Schaeverbeke T; Bourgeois P; Ravaud P; Fautrel B
J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
[TBL] [Abstract][Full Text] [Related]
8. Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort.
Roubille C; Rincheval N; Dougados M; Flipo RM; Daurès JP; Combe B
Ann Rheum Dis; 2017 Nov; 76(11):1797-1802. PubMed ID: 28213564
[TBL] [Abstract][Full Text] [Related]
9. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort.
Gottenberg JE; Dayer JM; Lukas C; Ducot B; Chiocchia G; Cantagrel A; Saraux A; Roux-Lombard P; Mariette X
Ann Rheum Dis; 2012 Jul; 71(7):1243-8. PubMed ID: 22532637
[TBL] [Abstract][Full Text] [Related]
10. Moderate alcohol consumption is associated with increased radiological progression in women, but not in men, with early rheumatoid arthritis: results from the ESPOIR cohort (Étude et Suivi des Polyarthrites Indifférenciées Récentes).
Sageloli F; Quesada JL; Fautrel B; Salliot C; Gaudin P; Baillet A
Scand J Rheumatol; 2018 Nov; 47(6):440-446. PubMed ID: 29774784
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis databases in Finland.
Sokka T
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S201-4. PubMed ID: 16273808
[TBL] [Abstract][Full Text] [Related]
12. Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort.
Louveau B; De Rycke Y; Lafourcade A; Saraux A; Guillemin F; Tubach F; Fautrel B; Hajage D
Rheumatology (Oxford); 2018 Sep; 57(9):1563-1573. PubMed ID: 29796624
[TBL] [Abstract][Full Text] [Related]
13. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
14. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.
Tournadre A; Pereira B; Dubost JJ; Rincheval N; Rat AC; Combe B; Soubrier M
Clin Exp Rheumatol; 2017; 35(2):296-302. PubMed ID: 28079508
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study.
Berglin E; Dahlqvist SR
Scand J Rheumatol; 2013; 42(5):362-8. PubMed ID: 23607599
[TBL] [Abstract][Full Text] [Related]
16. Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis.
Gwinnutt JM; Norton S; Hyrich KL; Lunt M; Combe B; Rincheval N; Ruyssen-Witrand A; Fautrel B; McWilliams DF; Walsh DA; Nikiphorou E; Kiely PDW; Young A; Chipping JR; MacGregor A; Verstappen SMM
Rheumatology (Oxford); 2022 Nov; 61(12):4687-4701. PubMed ID: 35274696
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of ACR/EULAR 2010 criteria for rheumatoid arthritis in a 2-year cohort.
Varache S; Cornec D; Morvan J; Devauchelle-Pensec V; Berthelot JM; Le Henaff-Bourhis C; Hoang S; Thorel JB; Martin A; Chalès G; Nowak E; Jousse-Joulin S; Youinou P; Saraux A
J Rheumatol; 2011 Jul; 38(7):1250-7. PubMed ID: 21572146
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
[TBL] [Abstract][Full Text] [Related]
19. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.
van Gestel AM; Anderson JJ; van Riel PL; Boers M; Haagsma CJ; Rich B; Wells G; Lange ML; Felson DT
J Rheumatol; 1999 Mar; 26(3):705-11. PubMed ID: 10090187
[TBL] [Abstract][Full Text] [Related]
20. An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.
Sokka T; Pincus T
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S178-81. PubMed ID: 16273804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
